ALGS

7.53

8.73% -0.72

Handel nachbörslich: 7.53

Aligos Therapeutics Inc (ALGS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ALGS? Forum Prognose

Schlusskurs vom Vortag:

$8.25

Offen:

$8.28

24-Stunden-Volumen:

80,888

Relative Volume:

1.01

Marktkapitalisierung:

$40.30M

Einnahmen:

$7.97M

Nettoeinkommen (Verlust:

$-75.74M

KGV:

-0.3101

EPS:

-24.2853

Netto-Cashflow:

$-85.33M

1W Leistung:

-22.93%

1M Leistung:

-25.22%

6M Leistung:

+34.46%

1J Leistung:

-21.15%

1-Tages-Spanne:

$7.4526

$8.469

1-Wochen-Bereich:

$7.4526

$10.06

52-Wochen-Spanne:

$3.76

$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Firmenname

Aligos Therapeutics Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

(800) 466-6059

Adresse

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

ALGS's Discussions on Twitter

Vergleichen Sie ALGS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALGS Aligos Therapeutics Inc	7.53	57.35M	7.97M	-75.74M	-85.33M	-24.29
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-18	Fortgesetzt	H.C. Wainwright	Buy
2024-08-19	Eingeleitet	H.C. Wainwright	Buy
2023-01-06	Hochstufung	Jefferies	Hold → Buy
2023-01-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-03-23	Herabstufung	Piper Sandler	Overweight → Neutral
2022-01-07	Herabstufung	JP Morgan	Overweight → Neutral
2022-01-06	Herabstufung	Jefferies	Buy → Hold
2021-09-09	Eingeleitet	SVB Leerink	Outperform
2021-05-17	Fortgesetzt	Piper Sandler	Overweight
2020-11-10	Eingeleitet	Cantor Fitzgerald	Overweight
2020-11-10	Eingeleitet	JP Morgan	Overweight
2020-11-10	Eingeleitet	Jefferies	Buy
2020-11-10	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten

09:50 AM

Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenarios2025 Performance Recap & Comprehensive Market Scan Insights - newser.com

09:50 AM

08:26 AM

Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Big Picture & Real-Time Price Movement Reports - newser.com

08:26 AM

07:32 AM

How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

07:32 AM

06:32 AM

When is the best time to exit Aligos Therapeutics Inc.Trade Entry Summary & Scalable Portfolio Growth Ideas - newser.com

06:32 AM

06:25 AM

How buybacks impact Aligos Therapeutics Inc. stock valueWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com

06:25 AM

05:41 AM

Why Aligos Therapeutics Inc. stock remains on buy listsJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com

05:41 AM

04:03 AM

How to forecast Aligos Therapeutics Inc. trends using time series2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

04:03 AM

02:08 AM

How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

02:08 AM

12:37 PM

Multi factor analysis applied to Aligos Therapeutics Inc.Dollar Strength & Safe Investment Capital Preservation Plans - newser.com

12:37 PM

Nov 02, 2025

Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in

Nov 02, 2025

Nov 01, 2025

Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025

Oct 31, 2025